Please select the option that best describes you:
Topics:
Thoracic Malignancies • Medical Oncology
Would you give consolidation durvalumab to a patient who underwent chemoradiation for his stage III NSCLC and is being started on antifibrotic therapy by pulmonology for his ILD?
How does the patient's pulmonary status and ECOG-PS play a role in your decision? This patient has an ECOG-PS of 0 and is on room air.